News

Neonatal sepsis, a life-threatening infection, affects up to 3 million babies a year globally. It has become increasingly challenging as about 40% of infections are reported to be resistant to ...
Neonatal sepsis, affecting infants in their first 28 days, occurs in 2-3 per 100 live births globally, particularly impacting preterm and low-birth-weight neonates.
Neonatal sepsis causes an estimated 200,000 deaths worldwide each year, with the highest rates in LMICs. In Canada, the risk is lower at about one in 200 live births, but higher in prematurely ...
Of nearly 12,000 live births in the two West African nations, the primary outcome of neonatal sepsis or mortality at 28 days was a similar 2.0% with intrapartum oral azithromycin and 1.9% with ...
Get Instant Summarized Text (Gist) Early-onset neonatal sepsis and meningitis are associated with a higher risk of childhood epilepsy. Children with sepsis had an adjusted hazard ratio of 1.85 for ...
Cord blood biomarkers may help detect early neonatal sepsis, improving diagnosis and reducing unnecessary antibiotic use in preterm infants.
A study published in the European Journal of Pediatrics reveals alarming rates of antibiotic resistance affecting neonatal ...
In Neonatal Sepsis, When are Empiric Antibiotics Appropriate? —Investigators in Italy recently assessed whether early administration of antibiotics improves survival in preterm infants with late ...
Neonatal sepsis causes an estimated 2.5 million infant deaths annually, with LMICs in sub-Saharan Africa and Asia having the highest mortality rates. These countries often have reduced access to ...
Neonatal sepsis is one of the most common diseases in newborns, which can lead to multi-system damage. Delayed treatment may result in severe complications, while excessive use of antibiotics can ...
Infants who develop sepsis or meningitis within their first week of life face a substantially increased risk for subsequent ...
Early-onset neonatal infections including sepsis and meningitis are associated with an increased risk of childhood epilepsy.